• Wed, March 30, 2022

by: WOPRAI

Daniel Imbro Maintained (ASO) at Buy with Increased Target to $70 on, Mar 30th, 2022

by: WOPRAI

Daniel Adam Maintained (ASO) at Strong Buy with Increased Target to $50 on, Mar 30th, 2022

by: WOPRAI

Nick Giovacchini Maintained (AVAH) at Buy with Decreased Target to $9.5 on, Mar 30th, 2022

by: WOPRAI

Sarah James Maintained (AVAH) at Buy with Decreased Target to $7 on, Mar 30th, 2022

by: WOPRAI

Scott Fidel Maintained (AVAH) at Buy with Decreased Target to $7 on, Mar 30th, 2022

by: WOPRAI

Pito Chickering Maintained (AVAH) at Strong Buy with Decreased Target to $6 on, Mar 30th, 2022

by: WOPRAI

David Macdonald Maintained (AVAH) at Strong Buy with Decreased Target to $5 on, Mar 30th, 2022

by: WOPRAI

Faiza Alwy Initiated (TRU) at Strong Buy and Held Target at $124 on, Mar 30th, 2022

by: WOPRAI

Michael Rehaut Maintained (TREX) at Sell with Decreased Target to $78 on, Mar 30th, 2022

by: WOPRAI

David Begleiter Initiated (TSE) at Strong Buy and Held Target at $60 on, Mar 30th, 2022

by: WOPRAI

Keith Hughes Maintained (TPX) at Strong Buy with Decreased Target to $37 on, Mar 30th, 2022

by: WOPRAI

Michael Rehaut Maintained (SWK) at Hold with Decreased Target to $170 on, Mar 30th, 2022

by: WOPRAI

Dennis Coleman Upgraded (SWX) to Strong Buy and Held Target at $88 on, Mar 30th, 2022

by: WOPRAI

Wesley Golladay Maintained (SUI) at Buy with Decreased Target to $205 on, Mar 30th, 2022

by: WOPRAI

Andrea Teixeira Maintained (TAP) at Sell with Decreased Target to $113 on, Mar 30th, 2022

by: WOPRAI

Amit Daryanani Maintained (TEL) at Buy and Held Target at $170 on, Mar 30th, 2022

by: WOPRAI

Anthony Crowdell Maintained (SRE) at Strong Buy with Increased Target to $87 on, Mar 30th, 2022

  • Tue, March 29, 2022

by: WOPRAI

Stephen Baxter Initiated (UHS) at Sell and Held Target at $139 on, Mar 29th, 2022

by: WOPRAI

Jiong Shao Maintained (XPEV) at Buy with Decreased Target to $39 on, Mar 29th, 2022

by: WOPRAI

Jeff Chung Maintained (XPEV) at Strong Buy with Decreased Target to $67 on, Mar 29th, 2022

by: WOPRAI

Seth Basham Maintained (WOOF) at Buy with Increased Target to $25 on, Mar 29th, 2022

by: WOPRAI

Srini Pajjuri Initiated (WOLF) at Buy and Held Target at $140 on, Mar 29th, 2022

by: WOPRAI

David Katz Maintained (CCL) at Hold with Decreased Target to $19 on, Mar 29th, 2022

by: WOPRAI

Mike Grondahl Maintained (SNAX) at Buy with Decreased Target to $60 on, Mar 29th, 2022

by: WOPRAI

Alex Fuhrman Maintained (SNAX) at Strong Buy with Decreased Target to $45 on, Mar 29th, 2022

by: WOPRAI

Brian Nowak Maintained (SNAP) at Buy with Decreased Target to $59 on, Mar 29th, 2022

by: WOPRAI

Dan Dolev Maintained (SQ) at Strong Buy with Increased Target to $215 on, Mar 29th, 2022

by: WOPRAI

Mayank Mamtani Maintained (TFFP) at Strong Buy with Decreased Target to $450 on, Mar 29th, 2022

by: WOPRAI

Kaumil Gajrawala Maintained (STZ) at Buy with Decreased Target to $278 on, Mar 29th, 2022

by: WOPRAI

Stephen Baxter Initiated (THC) at Buy and Held Target at $100 on, Mar 29th, 2022

by: WOPRAI

Adam Beatty Maintained (TPG) at Strong Buy with Decreased Target to $37 on, Mar 29th, 2022

by: WOPRAI

Rufus Hone Maintained (TPG) at Hold with Increased Target to $35 on, Mar 29th, 2022

by: WOPRAI

Brian Bedell Maintained (TPG) at Strong Buy with Increased Target to $43 on, Mar 29th, 2022

by: WOPRAI

Nathan Weinstein Initiated (TRVI) at Strong Buy and Held Target at $10 on, Mar 29th, 2022

by: WOPRAI

Joanna Gajuk Downgraded (AVAH) to Hold and Decreased Target to $5.5 on, Mar 29th, 2022

by: WOPRAI

Taylor Conrad Upgraded (AZO) to Strong Buy on, Mar 29th, 2022

by: WOPRAI

Chris Howerton Maintained (AXSM) at Strong Buy with Increased Target to $77 on, Mar 29th, 2022

by: WOPRAI

Daniel Day Maintained (AREN) at Strong Buy with Increased Target to $18 on, Mar 29th, 2022

by: WOPRAI

Matthew Broome Initiated (ANSS) at Hold and Held Target at $310 on, Mar 29th, 2022

by: WOPRAI

Paul Fremont Maintained (AEP) at Strong Buy with Increased Target to $104 on, Mar 29th, 2022

by: WOPRAI

Stefan Slowinski Initiated (ADBE) at Buy and Held Target at $570 on, Mar 29th, 2022

by: WOPRAI

Daina Graybosch Maintained (ACLX) at Buy with Decreased Target to $44 on, Mar 29th, 2022

by: WOPRAI

Judah Frommer Maintained (ABOS) at Buy with Decreased Target to $17 on, Mar 29th, 2022

by: WOPRAI

Julio Romero Upgraded (AAON) to Strong Buy and Held Target at $48 on, Mar 29th, 2022

by: WOPRAI

Raul Sinha Downgraded (BCS) to Hold on, Mar 29th, 2022

by: WOPRAI

Robert Driscoll Downgraded (BDTX) to Hold on, Mar 29th, 2022

by: WOPRAI

Benjamin Theurer Maintained (BHIL) at Buy with Decreased Target to $280 on, Mar 29th, 2022

by: WOPRAI

Faiza Alwy Initiated (BFAM) at Hold and Held Target at $114 on, Mar 29th, 2022

Nathan Weinstein Initiated (TRVI) at Strong Buy and Held Target at $10 on, Mar 29th, 2022

Nathan Weinstein of Aegis Capital, Initiated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $10 on, Mar 29th, 2022.

Nathan, nor any peers, have made any analyst calls on TRVI in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍